Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Maybe we are getting very close to M&A-- ( dys1)

"If you M&A IP, then you're back to points #1 & #2, particulary since PTSC indicated they would use TPL for further IP licensing income"

- Keep in mind that in the new IP.. the negoitations may be very different as TPL would not be a 50% owner of the IP that PTSC is selling. TPL would just be an authorized "seller" of the product. Of course they would recieve their % but i doubt its anywhere near 50%........ PTSC also would have control as to the prices, etc.

The MMP issue is different because TPL is a co-owner and we are going back to tell customers that are infringing.

PTSC can control some events... by working on that M&A or additional revenue stream. Since they havent -SP decline as the only visible revenues are the ones that are "uncertain or in doubt"...

PTSC long and strong....

1
Jun 17, 2008 11:36AM

Jun 17, 2008 11:36AM
Share
New Message
Please login to post a reply